XML 44 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements

The compensation cost that has been included in the Consolidated Statements of Operations for the Company’s stock-based compensation plans was as follows:

 

 

Year Ended December 31,

 

(in thousands)

 

2021

 

 

2020

 

 

2019

 

Selling, general and administrative expense

 

$

18,924

 

 

$

12,622

 

 

$

25,968

 

Research and development expense

 

 

6,112

 

 

 

5,259

 

 

 

3,798

 

Cost of sales

 

 

256

 

 

 

264

 

 

 

531

 

Stock-based compensation expense before taxes

 

 

25,292

 

 

 

18,145

 

 

 

30,297

 

Related income tax benefits

 

 

(4,391

)

 

 

(3,088

)

 

 

(6,191

)

Stock-based compensation expense, net of taxes

 

$

20,901

 

 

$

15,057

 

 

$

24,106

 

Summary of Restricted Stock Units

Following is a summary of RSU activity for the year ended December 31, 2021:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

(in thousands, except per share amounts)

 

Shares

 

 

Fair Value

 

Outstanding at December 31, 2020

 

 

994

 

 

$

58.94

 

Granted

 

 

412

 

 

 

61.85

 

Vested

 

 

(266

)

 

 

55.00

 

Forfeited

 

 

(148

)

 

 

60.88

 

Outstanding at December 31, 2021

 

 

992

 

 

$

60.91

 

Schedule of Performance-Based Restricted Stock Units

Following is a summary of PRSU activity for the year ended December 31, 2021:

 

 

 

 

 

 

Maximum Number

 

 

 

 

 

(in thousands, except per share amounts)

 

Shares

 

 

of Shares Eligible

to be Issued

 

 

Average Grant

Date Fair Value

 

Outstanding at December 31, 2020

 

 

619

 

 

 

850

 

 

$

57.38

 

Awarded at target

 

 

294

 

 

 

445

 

 

 

59.77

 

Vested

 

 

(105

)

 

 

(105

)

 

 

53.93

 

Forfeited

 

 

(139

)

 

 

(249

)

 

 

57.72

 

Outstanding at December 31, 2021

 

 

669

 

 

 

941

 

 

$

58.95

 

Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP

The weighted average assumptions used to estimate the fair value of stock options granted and stock purchase rights under the ESPP are as follows:

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

ESPP

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

39

%

 

 

56

%

 

 

35

%

Expected term (years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

Risk free interest rate

 

 

0.1

%

 

 

0.5

%

 

 

2.3

%

Expected dividend yield

 

 

%

 

 

%

 

 

%

Common Stock Reserved for Future Issuance

Common Stock Reserved for Future Issuance

The following table summarizes common shares reserved for issuance on exercise or conversion at December 31, 2021:

(in thousands)

 

 

 

 

Issued and outstanding RSUs and PRSUs

 

 

1,678

 

Available for issuance under the ESPP

 

 

676

 

Available for future grant

 

 

3,359

 

2023 Notes

 

 

7,082

 

2023 Warrants

 

 

6,949

 

2025 Notes

 

 

6,512

 

2025 Warrants

 

 

6,271

 

Total shares reserved for future issuance

 

 

32,527